ESCC patients with higher mRNA levels of MMS22L (HR = 0.33; CI: 0.14−0.75; logrank p = 0.0052) and MUC13 (HR = 0.37; CI: 0.14−0.96; logrank p = 0.033) had higher OS (Figures 3A, B), and ESCC patients with lower mRNA levels of VAPA (HR = 2.32; CI: 1.04−5.17; logrank p = 0.035), CYP1B1 (HR = 2.67; CI: 1.02−6.97; logrank p = 0.039), and UBC (HR = 2.26; CI: 1.03−4.96; logrank p = 0.038) had higher OS (Figures 3C–E), while the mRNA expression of UGDH, MME and CUL13 were not associated with ESCC patient survival (Figures 3F–H). This evidence concerns the gene VAPA and esophageal squamous cell carcinoma.